Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-077389
Filing Date
2025-05-27
Accepted
2025-05-27 08:00:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A sip-defa14a_2025.htm DEFA14A 63183
2 GRAPHIC img203144465_0.jpg GRAPHIC 30760
  Complete submission text file 0000950170-25-077389.txt   106655
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38327 | Film No.: 25984307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)